Protecting the Brain from Toxic Tangles: Scientists Discover a Protein That May Fight Alzheimer’s
July 21, 08:00
In experiments on mice, researchers at Sanford Burnham Prebys have found that a protein called SORLA can defend the brain against damage linked to Alzheimer’s disease. SORLA works by reducing the buildup of the toxic tau protein, slowing brain shrinkage, and helping preserve synapses—the critical connections that allow nerve cells to communicate. Alzheimer’s is the most common form of dementia, affecting millions worldwide, and current treatments remain limited.
Key Findings from the Study
Mice engineered to have higher levels of SORLA showed significant benefits. Specifically, the SORLA protein:
- slowed the formation of harmful tau clumps;
- reduced excessive chemical changes to tau that cause it to stick together;
- prevented the spread of already-damaged proteins.
These mice also retained more synapses, experienced less brain atrophy, and accumulated less tau. In contrast, mice unable to produce SORLA due to a missing Sorl1 gene suffered far greater brain damage.
The researchers note that SORLA’s effects extend beyond neurons to glial cells. Without SORLA, certain receptors in glial cells became more active. Drugs that target these receptors already exist. According to the Sanford Burnham Prebys team,
“boosting SORLA levels suppresses the negative processes typical of tau-related diseases.”
The next phase of research will focus on understanding how SORLA functions in human nerve cells. These findings could pave the way for new therapeutic strategies to combat Alzheimer’s disease, one of the most widespread forms of dementia.
Legal disclaimer. This article provides general reference information and should not be taken as a substitute for medical advice. NV is not responsible for any diagnosis readers may make based on site content. NV also assumes no responsibility for the content of external websites linked in this article. If you have health concerns, consult a doctor.
This research into the SORLA protein opens up new possibilities for understanding how Alzheimer’s develops and how it might be treated. Finding ways to increase SORLA levels could become a key element in developing therapies that slow the disease’s progression. Further studies focusing on human cells will be essential to turn these discoveries into practical treatments, marking an important step forward in the fight against dementia.
Understanding the complex mechanisms behind Alzheimer’s disease is crucial for developing effective treatments. Recent research highlights how molecular interactions within neurons may play a significant role in triggering this condition. For a deeper insight into these processes, explore how neural dynamics contribute to Alzheimer's onset.